About 10 results found for searched term "82-08-6" (0.057 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2182 | RG108 | DNA Methyltransferase |
| N-Phthalyl-L-tryptophan | ||
| RG108 is a novel small-molecule inhibitors of DNA methyltransferases with IC50 of 115 nM. | ||
| M5116 | Formoterol Hemifumarate | Adrenergic Receptor |
| Eformoterol, CGP 25827A, NSC 299587, YM 08316 | ||
| Formoterol Hemifumarate is a potent, selective and long-acting β2-adrenoceptor agonist used in the management of asthma and chronic obstructive pulmonary disease. | ||
| M8141 | Rottlerin | PKC |
| Recently, Rottlerin (mallotoxin) has been shown to be a potent activator of the large conductance voltage and Ca2 activated K+ channel and to potently leftward shift the conductance-voltage relationship of the channel. | ||
| M16378 | Deacetylpseudolaric acid C2 | Diterpenoids |
| Deacetylpseudolaric acid C2 | ||
| M18150 | PHOSPHATIDYLETHANOLAMINE (PE) | Others |
| PHOSPHATIDYLETHANOLAMINE (PE) | ||
| M21179 | TAK-071 | Others |
| TAK-071 is a novel, potent and selective modulator of muscarinic acetylcholine receptor 1 (M1R) orthostructure. TAK-071 activates M1R with an EC50 of 520 nM. | ||
| M21215 | CP-628006 | CFTR |
| CP-628006 is a CFTR small molecule enhancer that enhances CFTR function in human bronchial epithelial (hBE) cells and restores ATP-dependent gated channels in cystic fibrosis mutant G551D-CFTR. It can be used in cystic fibrosis (CF) related studies. | ||
| M30050 | GSK-3 Inhibitor XIII | GSK-3 |
| GSK-3 Inhibitor XIII is a potent and ATP-competitive GSK-3 inhibitor with a Ki of 24 nM. | ||
| M31289 | Liafensine | 5-HT Receptor |
| BMS-820836 | ||
| Liafensine (BMS-820836) is a selective triple reuptake inhibitor of serotonin (5-HT), norepinephrine and dopamine. It may be used in studies related to depression. | ||
| M42620 | 7-Methoxy obtusifolin | Tyrosinase |
| 7-Methoxy obtusifolin is a competitive tyrosinase inhibitor with an IC50 of 7.0 μM. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
